13 New CBMNet Projects Funded
We are pleased to announce that we have recently funded 13 new projects in Industrial Biotechnology and Bioenergy.
- Dr Neil Dixon, University of Manchester, CPI and Oxford Biotrans – Identification of Membrane Transporters of Lignin monomers
- Professor David James, University of Sheffield and UCB Pharma – Engineering Exosome Production by CHO Cells
- Professor Doug Kell, University of Manchester and Croda – A potent synthetic biology strategy for increasing transporter-mediated terpenoid efflux from E. coli
Business Interaction Vouchers
- Dr Mark Shepherd, University of Kent and FujiFilm – Engineering E. coli for enhanced production of antibody fragments
- Dr Mark Shepherd, University of Kent and FujiFilm – Lowering the disulphide load in the periplasm of E. coli cell factories
- Dr Teuta Pilizota, University of Edinburgh and FujiFilm – Replacing osmotic downshocks with upshocks for periplasmic protein extraction
- Dr Frans Maathuis, University of York – The role of HMA and COPT proteins in trans membrane movement of palladium
- Professor Colin Robinson, University of Kent – An enhanced platform for translocation of biotherapeutics to the E. coli periplasm
- Dr Alan Goddard, University of Lincoln – Modelling of multifactorial solvent stress on membranes
- Dr Wuge Briscoe, University of Bristol – Bacterial mimicking liposomes
- Dr Boyan Bonev, University of Nottingham – Membrane stability models in the presence of methacrylate esters
- Dr Sam Miller, University of Aberdeen – Investigating the role of periplasmic and transmembrane domains of mechanosensitive channels in E.coli membrane integrity
- Dr Claudio Avignone-Rossa, University of Surrey – Construction of glucose transporter mutants of Clostridium beijerinckii
You can view all our projects funded to date here and read our success stories here.
From January 1st 2016, we are pleased to announce the the following will be joining our management board:
- Dr Sam Miller (University of Aberdeen)
Sam is currently a lecturer in the School of Medical Sciences. Her research career is focussed on structure and function relationships in two sets of ion channels in Escherichia coli involved in bacterial survival of changes in their environments.
- Dr Lars Jeuken (University of Leeds)
Lars is a Reader in Biophysics in the Faculty of Biological Sciences. He researches redox-active membrane proteins and biological electron transfer, with the aim of controlling the interaction between biological macromolecules and inorganic ‘solid’ surfaces.
- Ian Hodgson (FujiFilm Diosynth Biotechnologies)
Ian is the Head of Molecular Biology, R & D at FujiFilm Diosynth Biotechnologies, based in Billingham. He has over 26 years of experience in molecular biology and in particular the design, construction and testing of protein expression vectors for biopharmaceutical production (eukaryotic and prokaryotic).
- Dr Doug Cossar (Croda Europe Ltd)
Doug took up his present position at Croda Europe Ltd, to manage the Biotechnology Research Group in Widnes. His role is to develop route to manufacture for biotechnology-derived speciality chemicals for delivery across an array of market sectors, from Health Care (eg excipients for drug formulation or speciality lipids) to the Oil Field (surface-active materials).
The CBMNet Management Board oversees the strategic goals of the network; delivery and dissemination of innovative approaches relevant to remit; promotion of academic-industrial interactions; processes for inviting, assessing and allocating Proof-of-Concept funding; reviewing strategic goals and network events.